Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah S Burns

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Cell Stem Cell|August 5, 2022
Turning the clock forward: Inflammation accelerates the aging of hematopoietic stem cellsSarah S Burns, Reuben Kapur
Stem Cell Reports|August 1, 2020
Putative Mechanisms Underlying Cardiovascular Disease Associated with Clonal Hematopoiesis of Indeterminate PotentialSarah S Burns, Reuben Kapur
Stem Cell Reports|August 14, 2020
Clonal Hematopoiesis of Indeterminate Potential as a Novel Risk Factor for Donor-Derived LeukemiaSarah S Burns, Reuben Kapur
Methods in Molecular Biology (Clifton, N.J.)|June 5, 2016
Generation of Noninvasive, Quantifiable, Orthotopic Animal Models for NF2-Associated Schwannoma and MeningiomaSarah S Burns, Long-Sheng Chang
Expert Opinion on Therapeutic Targets|May 3, 2022
Targeting SHP2 phosphatase in hematological malignanciesRahul Kanumuri, Santhosh Kumar Pasupuleti, Sarah S Burns, et al.
Gene Regulation and Systems Biology|January 8, 2010
Evolution and origin of HRS, a protein interacting with Merlin, the Neurofibromatosis 2 gene productLeonid V Omelyanchuk, Julia A Pertseva, Sarah S Burns, et al.
Cancer Research Communications|December 19, 2025
Combining brigatinib with mTOR inhibition to effectively treat NF2-SWN-associated and sporadic NF2-deficient meningiomasLong-Sheng Chang, Janet L Oblinger, Lai Man Natalie Wu, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|January 7, 2012
Treatment of vestibular schwannoma cells with ErbB inhibitorsMatthew L Bush, Sarah S Burns, Janet Oblinger, et al.
Stem Cell Reports|June 6, 2020
Driver Mutations in Leukemia Promote Disease Pathogenesis through a Combination of Cell-Autonomous and Niche ModulationBaskar Ramdas, Raghuveer Singh Mali, Lakshmi Reddy Palam, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|August 10, 2013
Natural compounds as potential treatments of NF2-deficient schwannoma and meningioma: cucurbitacin D and goyazensolideSamuel A Spear, Sarah S Burns, Janet L Oblinger, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Cell Stem Cell|August 5, 2022
Turning the clock forward: Inflammation accelerates the aging of hematopoietic stem cellsSarah S Burns, Reuben Kapur
Stem Cell Reports|August 1, 2020
Putative Mechanisms Underlying Cardiovascular Disease Associated with Clonal Hematopoiesis of Indeterminate PotentialSarah S Burns, Reuben Kapur
Stem Cell Reports|August 14, 2020
Clonal Hematopoiesis of Indeterminate Potential as a Novel Risk Factor for Donor-Derived LeukemiaSarah S Burns, Reuben Kapur
Methods in Molecular Biology (Clifton, N.J.)|June 5, 2016
Generation of Noninvasive, Quantifiable, Orthotopic Animal Models for NF2-Associated Schwannoma and MeningiomaSarah S Burns, Long-Sheng Chang
Expert Opinion on Therapeutic Targets|May 3, 2022
Targeting SHP2 phosphatase in hematological malignanciesRahul Kanumuri, Santhosh Kumar Pasupuleti, Sarah S Burns, et al.
Gene Regulation and Systems Biology|January 8, 2010
Evolution and origin of HRS, a protein interacting with Merlin, the Neurofibromatosis 2 gene productLeonid V Omelyanchuk, Julia A Pertseva, Sarah S Burns, et al.
Cancer Research Communications|December 19, 2025
Combining brigatinib with mTOR inhibition to effectively treat NF2-SWN-associated and sporadic NF2-deficient meningiomasLong-Sheng Chang, Janet L Oblinger, Lai Man Natalie Wu, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|January 7, 2012
Treatment of vestibular schwannoma cells with ErbB inhibitorsMatthew L Bush, Sarah S Burns, Janet Oblinger, et al.
Stem Cell Reports|June 6, 2020
Driver Mutations in Leukemia Promote Disease Pathogenesis through a Combination of Cell-Autonomous and Niche ModulationBaskar Ramdas, Raghuveer Singh Mali, Lakshmi Reddy Palam, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|August 10, 2013
Natural compounds as potential treatments of NF2-deficient schwannoma and meningioma: cucurbitacin D and goyazensolideSamuel A Spear, Sarah S Burns, Janet L Oblinger, et al.
Pageof 3